Abstract Number: 1176 • 2018 ACR/ARHP Annual Meeting
Experiences of Urban First Nations and Métis Patients Accessing and Navigating the Health System for Inflammatory Arthritis Care
Background/Purpose: Outcome inequities exist for Indigenous patients in Canada with inflammatory arthritis conditions. Primary health services innovations that better support urban Indigenous patients exist, but…Abstract Number: 1177 • 2018 ACR/ARHP Annual Meeting
How Are Patients with Chronic Musculoskeletal Pain Conditions Being Managed Initially in the U.S.?
Background/Purpose: Chronic musculoskeletal pain (e.g. back and neck pain, pain due to arthritis, leg pain, arm pain) affects up to 24% of the general population.…Abstract Number: 1178 • 2018 ACR/ARHP Annual Meeting
Patients’ and Healthcare Professionals’ Resource Preferences for a Knowledge Translation Toolkit for Hip and Knee Replacement Rehabilitation
Background/Purpose: Widely varying rehabilitation practices for total joint replacement (TJR) for hip and knee osteoarthritis (OA) contribute to inconsistent patient outcomes and satisfaction. Informed by…Abstract Number: 1179 • 2018 ACR/ARHP Annual Meeting
Achieving Important Improvement in WOMAC Pain and Function By Three Months Post-Surgery Influences Satisfaction 1 Year Following Total Knee Replacement (TKR)
Background/Purpose: Understanding the impact of the time of achievement of important improvement (II) in pain and function may further understanding of outcome and inform care…Abstract Number: 1180 • 2018 ACR/ARHP Annual Meeting
The Economic Burden of Systemic Lupus Erythematosus (SLE) within a Commercially-Insured Population in the United States Stratified By Disease Severity
Background/Purpose: Most currently available estimates of the economic burden of SLE in the US do not consider disease severity. The purpose of this study is…Abstract Number: 1181 • 2018 ACR/ARHP Annual Meeting
Hydroxychloroquine: Do We All See Eye to Eye? a Single-Site Analysis of Hydroxychloroquine Dosing Compared to 2016 American Academy of Ophthalmology Guidelines
Background/Purpose: Hydroxychloroquine is universally recommended to treat patients with SLE, stressing the importance of appropriate dosing. The 2016 American Academy of Ophthalmology (AAO) guidelines recommend…Abstract Number: 1182 • 2018 ACR/ARHP Annual Meeting
The Disproportionate High Risk of Re-Fracture after Osteoporotic Treatment in Patients with Autoimmune Diseases
Background/Purpose: Patients with autoimmune diseases are associated with an increased risk of osteoporotic fracture. Anti-osteoporotic treatment could diminish re-fracture rates in post-menopause women. However, treatment…Abstract Number: 1183 • 2018 ACR/ARHP Annual Meeting
The Distribution of Insurance in a Population-Based Cohort of SLE: Georgians Organized Against Lupus Cohort, 2012-2016
Background/Purpose: Having health insurance coverage is important for people with chronic conditions. Those with systemic lupus erythematosus (SLE) are particularly vulnerable given the disproportionate impact…Abstract Number: 1184 • 2018 ACR/ARHP Annual Meeting
Withdrawn
WithdrawnAbstract Number: 1185 • 2018 ACR/ARHP Annual Meeting
Cause and Rate of Hospitalization of Lupus Patients
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic multiorgan disease that is associated with significant morbidity and mortality. Literature suggests improvement in the survival rates…Abstract Number: 1186 • 2018 ACR/ARHP Annual Meeting
Comparison of Biologic Discontinuation in Patients with Elderly-Onset Vs Younger-Onset Rheumatoid Arthritis
Background/Purpose: Several studies have suggested that patients with elderly-onset rheumatoid arthritis (EORA) receive biologic treatments less frequently than patients with younger-onset RA (YORA). This has…Abstract Number: 1187 • 2018 ACR/ARHP Annual Meeting
Impact of a Nurse-Led Program of Patient Self-Assessment and Self-Management Axial Spondyloarthritis: Results of a Prospective, Multicentre, Randomized, Controlled Trial
Background/Purpose: The objective of this study was to evaluate the impact of a nurse- led program of self-management and self-assessment for disease activity program in…Abstract Number: 1188 • 2018 ACR/ARHP Annual Meeting
Are Residents Choosing Wisely? Analysis of Adherence to Recommendations of Ordering Anti-Nuclear Antibody Testing in an Internal Medicine Residency Primary Care Clinic
Background/Purpose: A positive anti-nuclear antibody (ANA) is considered very useful for the diagnosis of SLE and systemic sclerosis, and somewhat useful for the diagnosis of…Abstract Number: 1189 • 2018 ACR/ARHP Annual Meeting
Secukinumab Versus Adalimumab for the Treatment of Ankylosing Spondylitis: A Cost per Responder Analysis from Korean Perspective
Secukinumab versus Adalimumab for the Treatment of Ankylosing Spondylitis: A Cost per Responder Analysis from Korean PerspectiveDam Kim1, Hyojin Kim2, SeongHa Cho2, Min-Chan Park11Division of…Abstract Number: 1190 • 2018 ACR/ARHP Annual Meeting
Use of Biologic Drugs and Adverse Events in Patients with Rheumatic Disease: DATA from the Mexican Biologics Registry
Background/Purpose: National registries of biologic drugs have proven to be valuable tools in following patients with rheumatic disease and some outcomes in real-life situations. The…